Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

PI-RADS version 2.1: one small step for prostate MRI.

Barrett T, Rajesh A, Rosenkrantz AB, Choyke PL, Turkbey B.

Clin Radiol. 2019 Jun 22. pii: S0009-9260(19)30259-4. doi: 10.1016/j.crad.2019.05.019. [Epub ahead of print] Review.

PMID:
31239107
2.

Fully automated prostate whole gland and central gland segmentation on MRI using holistically nested networks with short connections.

Cheng R, Lay N, Roth HR, Turkbey B, Jin D, Gandler W, McCreedy ES, Pohida T, Pinto P, Choyke P, McAuliffe MJ, Summers RM.

J Med Imaging (Bellingham). 2019 Apr;6(2):024007. doi: 10.1117/1.JMI.6.2.024007. Epub 2019 Jun 5.

PMID:
31205977
3.

PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Padhani AR, Barentsz J, Villeirs G, Rosenkrantz AB, Margolis DJ, Turkbey B, Thoeny HC, Cornud F, Haider MA, Macura KJ, Tempany CM, Verma S, Weinreb JC.

Radiology. 2019 Aug;292(2):464-474. doi: 10.1148/radiol.2019182946. Epub 2019 Jun 11.

PMID:
31184561
4.
5.

Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance.

Bloom JB, Lebastchi AH, Gold SA, Hale GR, Sanford T, Mehralivand S, Ahdoot M, Rayn KN, Czarniecki M, Smith C, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

BJU Int. 2019 May 29. doi: 10.1111/bju.14835. [Epub ahead of print]

PMID:
31141307
6.

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 May 16. doi: 10.1007/s11255-019-02168-4. [Epub ahead of print]

PMID:
31098818
7.

Artificial intelligence at the intersection of pathology and radiology in prostate cancer.

Harmon SA, Tuncer S, Sanford T, Choyke PL, Türkbey B.

Diagn Interv Radiol. 2019 May;25(3):183-188. doi: 10.5152/dir.2019.19125.

8.

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.

Gold SA, VanderWeele DJ, Harmon S, Bloom JB, Karzai F, Hale GR, Marhamati S, Rayn KN, Mehralivand S, Merino MJ, Gulley JL, Bilusic M, Madan RA, Choyke PL, Turkbey B, Dahut W, Pinto PA.

Urol Oncol. 2019 Jun;37(6):352.e25-352.e30. doi: 10.1016/j.urolonc.2019.01.012. Epub 2019 Apr 15.

PMID:
31000430
9.

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

Greer MD, Shih JH, Lay N, Barrett T, Bittencourt L, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536. [Epub ahead of print]

PMID:
30917023
10.

First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Kurdziel KA, Mena E, McKinney Y, Wong K, Adler S, Sissung T, Lee J, Lipkowitz S, Lindenberg L, Turkbey B, Kummar S, Milenic DE, Doroshow JH, Figg WD, Merino MJ, Paik CH, Brechbiel MW, Choyke PL.

J Transl Sci. 2019 Apr;5(2). doi: 10.15761/JTS.1000269. Epub 2018 Jul 13.

11.

Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.

Sedghi A, Pesteie M, Javadi G, Azizi S, Yan P, Kwak JT, Xu S, Turkbey B, Choyke P, Pinto P, Wood B, Rohling R, Abolmaesumi P, Mousavi P.

Int J Comput Assist Radiol Surg. 2019 Jun;14(6):1009-1016. doi: 10.1007/s11548-019-01950-0. Epub 2019 Mar 23.

PMID:
30905010
12.

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC.

Eur Urol. 2019 Mar 18. pii: S0302-2838(19)30180-0. doi: 10.1016/j.eururo.2019.02.033. [Epub ahead of print] Review.

PMID:
30898406
13.

Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?

Sackett J, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 19:1-9. doi: 10.2214/AJR.19.21178. [Epub ahead of print]

PMID:
30888865
14.

Contemporary treatments in prostate cancer focal therapy.

Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA.

Curr Opin Oncol. 2019 May;31(3):200-206. doi: 10.1097/CCO.0000000000000515.

PMID:
30865133
15.

Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks.

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2018 Oct;5(4):044507. doi: 10.1117/1.JMI.5.4.044507. Epub 2018 Dec 15.

PMID:
30840728
16.

Novel Imaging in Detection of Metastatic Prostate Cancer.

Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B.

Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8. Review.

PMID:
30834999
17.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion.

Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL.

Oncotarget. 2018 Dec 28;9(102):37676-37688. doi: 10.18632/oncotarget.26481. eCollection 2018 Dec 28.

18.

Prostate Magnetic Resonance Imaging: Lesion Detection and Local Staging.

Turkbey B, Choyke PL.

Annu Rev Med. 2019 Jan 27;70:451-459. doi: 10.1146/annurev-med-053117-123215.

PMID:
30691375
19.

When to Biopsy the Seminal Vesicles: A Validated Multiparametric Magnetic Resonance Imaging and Target Driven Model to Detect Seminal Vesicle Invasion in Prostate Cancer.

Gold SA, Shih JH, Rais-Bahrami S, Bloom JB, Vourganti S, Singla N, Baroni RH, Coker MA, Fialkoff J, Noschang J, Roehrborn CG, Turkbey B, Pinto PA; Collaborators.

J Urol. 2019 Jan 23. doi: 10.1097/JU.0000000000000112. [Epub ahead of print]

PMID:
30681511
20.

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2019 Mar;290(3):709-719. doi: 10.1148/radiol.2018181278. Epub 2019 Jan 22.

PMID:
30667329
21.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30577395
22.

Intra- and interreader reproducibility of PI-RADSv2: A multireader study.

Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, An JY, Czarniecki M, Mehralivand S, Coskun M, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2019 Jun;49(6):1694-1703. doi: 10.1002/jmri.26555. Epub 2018 Dec 21.

PMID:
30575184
23.

Sentinel lymph node imaging in urologic oncology.

Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B.

Transl Androl Urol. 2018 Oct;7(5):887-902. doi: 10.21037/tau.2018.08.23. Review.

24.

Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents.

Czarniecki M, Mena E, Lindenberg L, Cacko M, Harmon S, Radtke JP, Giesel F, Turkbey B, Choyke PL.

Transl Androl Urol. 2018 Oct;7(5):831-843. doi: 10.21037/tau.2018.08.03. Review.

25.

Detection of lymph node metastases in genitourinary cancers.

Turkbey B.

Transl Androl Urol. 2018 Oct;7(5):765. doi: 10.21037/tau.2018.09.13. No abstract available.

26.

A collaborative computer aided diagnosis (C-CAD) system with eye-tracking, sparse attentional model, and deep learning.

Khosravan N, Celik H, Turkbey B, Jones EC, Wood B, Bagci U.

Med Image Anal. 2019 Jan;51:101-115. doi: 10.1016/j.media.2018.10.010. Epub 2018 Oct 28.

PMID:
30399507
27.

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer.

Czarniecki M, Pesapane F, Wood BJ, Choyke PL, Turkbey B.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S453-S461. doi: 10.21037/tau.2018.05.15. Review.

28.

Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation.

Gaur S, Lay N, Harmon SA, Doddakashi S, Mehralivand S, Argun B, Barrett T, Bednarova S, Girometti R, Karaarslan E, Kural AR, Oto A, Purysko AS, Antic T, Magi-Galluzzi C, Saglican Y, Sioletic S, Warren AY, Bittencourt L, Fütterer JJ, Gupta RT, Kabakus I, Law YM, Margolis DJ, Shebel H, Westphalen AC, Wood BJ, Pinto PA, Shih JH, Choyke PL, Summers RM, Turkbey B.

Oncotarget. 2018 Sep 18;9(73):33804-33817. doi: 10.18632/oncotarget.26100. eCollection 2018 Sep 18.

29.

Magnetic Resonance Imaging-Based Prediction of Prostate Cancer Risk-Reply.

Mehralivand S, Shih J, Turkbey B.

JAMA Oncol. 2018 Nov 1;4(11):1625. doi: 10.1001/jamaoncol.2018.4234. No abstract available.

PMID:
30326079
30.

Imaging of distant metastases of prostate cancer.

Pesapane F, Czarniecki M, Suter MB, Turkbey B, Villeirs G.

Med Oncol. 2018 Sep 14;35(11):148. doi: 10.1007/s12032-018-1208-2. Review.

PMID:
30218382
31.

Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.

Rayn KN, Hale GR, Bloom JB, Gold SA, Carvalho FLF, Mehralivand S, Czarniecki M, Wood BJ, Merino MJ, Choyke P, Türkbey B, Pinto PA, Agarwal PK.

Diagn Interv Radiol. 2018 Sep;24(5):316-320. doi: 10.5152/dir.2018.18102. Review.

32.

Editorial Comment.

Turkbey B.

J Urol. 2018 Nov;200(5):1028-1029. doi: 10.1016/j.juro.2018.06.084. Epub 2018 Aug 9. No abstract available.

PMID:
30098949
33.

Deep dense multi-path neural network for prostate segmentation in magnetic resonance imaging.

To MNN, Vu DQ, Turkbey B, Choyke PL, Kwak JT.

Int J Comput Assist Radiol Surg. 2018 Nov;13(11):1687-1696. doi: 10.1007/s11548-018-1841-4. Epub 2018 Aug 7.

34.

Alström syndrome: Renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH clinical center.

Waldman M, Han JC, Reyes-Capo DP, Bryant J, Carson KA, Turkbey B, Choyke P, Naggert JK, Gahl WA, Marshall JD, Gunay-Aygun M.

Mol Genet Metab. 2018 Sep;125(1-2):181-191. doi: 10.1016/j.ymgme.2018.07.010. Epub 2018 Jul 24.

PMID:
30064963
35.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30063928
36.

Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Gaur S, Turkbey B.

Urol Clin North Am. 2018 Aug;45(3):467-479. doi: 10.1016/j.ucl.2018.03.011. Review.

PMID:
30031466
37.

Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.

Barret E, Turkbey B, Puech P, Durand M, Panebianco V, Fütterer JJ, Renard-Penna R, Rouvière O.

World J Urol. 2019 Mar;37(3):429-436. doi: 10.1007/s00345-018-2395-3. Epub 2018 Jul 12.

PMID:
30003373
38.

Deep Recurrent Neural Networks for Prostate Cancer Detection: Analysis of Temporal Enhanced Ultrasound.

Azizi S, Bayat S, Yan P, Tahmasebi A, Kwak JT, Xu S, Turkbey B, Choyke P, Pinto P, Wood B, Mousavi P, Abolmaesumi P.

IEEE Trans Med Imaging. 2018 Dec;37(12):2695-2703. doi: 10.1109/TMI.2018.2849959. Epub 2018 Jun 25.

PMID:
29994471
39.

Surveillance after prostate focal therapy.

Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, Montironi R, Muto S, Rastinehad AR, Turkbey B, Villers A, Polascik TJ.

World J Urol. 2019 Mar;37(3):397-407. doi: 10.1007/s00345-018-2363-y. Epub 2018 Jun 9.

PMID:
29948045
40.

Comparison of Elastic and Rigid Registration during Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy: A Multi-Operator Phantom Study.

Hale GR, Czarniecki M, Cheng A, Bloom JB, Seifabadi R, Gold SA, Rayn KN, Sabarwal VK, Mehralivand S, Choyke PL, Turkbey B, Wood B, Pinto PA.

J Urol. 2018 Nov;200(5):1114-1121. doi: 10.1016/j.juro.2018.06.028. Epub 2018 Jun 22.

PMID:
29940248
41.

Radiomics and radiogenomics of prostate cancer.

Smith CP, Czarniecki M, Mehralivand S, Stoyanova R, Choyke PL, Harmon S, Turkbey B.

Abdom Radiol (NY). 2019 Jun;44(6):2021-2029. doi: 10.1007/s00261-018-1660-7.

PMID:
29926137
42.

Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J.

Eur Urol. 2019 Mar;75(3):385-396. doi: 10.1016/j.eururo.2018.05.035. Epub 2018 Jun 13.

43.

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.

Rayn KN, Bloom JB, Gold SA, Hale GR, Baiocco JA, Mehralivand S, Czarniecki M, Sabarwal VK, Valera V, Wood BJ, Merino MJ, Choyke P, Turkbey B, Pinto PA.

J Urol. 2018 Nov;200(5):1041-1047. doi: 10.1016/j.juro.2018.05.094. Epub 2018 May 29.

PMID:
29852182
44.

Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.

Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ, Turkbey B.

Radiology. 2018 Aug;288(2):485-491. doi: 10.1148/radiol.2018170425. Epub 2018 May 22.

PMID:
29786491
45.

Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

Gold SA, Hale GR, Bloom JB, Smith CP, Rayn KN, Valera V, Wood BJ, Choyke PL, Turkbey B, Pinto PA.

World J Urol. 2019 Feb;37(2):235-241. doi: 10.1007/s00345-018-2337-0. Epub 2018 May 21. Review.

PMID:
29785491
46.

"Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.

Bloom JB, Gold SA, Hale GR, Rayn KN, Sabarwal VK, Bakhutashvili I, Valera V, Turkbey B, Pinto PA, Wood BJ.

Gland Surg. 2018 Apr;7(2):166-187. doi: 10.21037/gs.2018.03.06. Review.

47.

Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.

Sidana A, Watson MJ, George AK, Rastinehad AR, Vourganti S, Rais-Bahrami S, Muthigi A, Maruf M, Gordetsky JB, Nix JW, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.

Urol Oncol. 2018 Jul;36(7):341.e1-341.e7. doi: 10.1016/j.urolonc.2018.04.002. Epub 2018 May 10.

PMID:
29753548
48.

Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

An JY, Harmon SA, Mehralivand S, Czarniecki M, Smith CP, Peretti JA, Wood BJ, Pinto PA, Choyke PL, Shih JH, Turkbey B.

Abdom Radiol (NY). 2018 Dec;43(12):3436-3444. doi: 10.1007/s00261-018-1631-z.

PMID:
29752491
49.

PI-RADS v2: Current standing and future outlook.

Smith CP, Türkbey B.

Turk J Urol. 2018 May;44(3):189-194. doi: 10.5152/tud.2018.12144. Epub 2018 May 1. Review.

50.

Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.

Gaur S, Harmon S, Rosenblum L, Greer MD, Mehralivand S, Coskun M, Merino MJ, Wood BJ, Shih JH, Pinto PA, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2018 Jul;211(1):W33-W41. doi: 10.2214/AJR.17.18702. Epub 2018 May 7.

PMID:
29733695

Supplemental Content

Loading ...
Support Center